Interaction of p53 with tumor suppressive and oncogenic signaling pathways to control cellular reactive oxygen species production

Antioxidants and Redox Signaling

Volumn 15, Issue 6, 2011, Pages 1749-1761

  Ladelfa, María Fátima ^a   Toledo, María Fernanda ^a   Laiseca, Julieta Eva ^a   Monte, Martín ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; HYPOXIA INDUCIBLE FACTOR; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SMAD PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

APOPTOSIS; CELL PROLIFERATION; HUMAN; HYPOXIA; METABOLIC REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

APOPTOSIS; GENOMIC INSTABILITY; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASMS; ONCOGENES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEIN P53; WNT PROTEINS;

EID: 79960027346     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2010.3652     Document Type: Review

References (167)

1. Adibhatla RM and Hatcher JF. Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 12: 125-169, 2010.
2. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV, and Neckers LM. Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature 392: 405-408, 1998.
3. Barker N, Morin PJ, and Clevers H. The Yin-Yang of TCF=beta-catenin signaling. Adv Cancer Res 77: 1-24, 2000.
4. Bell EL, Klimova TA, Eisenbart J, Moraes CT, Murphy MP, Budinger GR, and Chandel NS. The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production. J Cell Biol 177: 1029-1036, 2007. (Pubitemid 46955707)
5. Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R, Gottlieb E, and Vousden KH. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126: 107-120, 2006. (Pubitemid 44040989)
6. Bensaad K and Vousden KH. p53: new roles in metabolism. Trends Cell Biol 17: 286-291, 2007. (Pubitemid 46829848)
7. Black D, Bird MA, Samson CM, Lyman S, Lange PA, Schrum LW, Qian T, Lemasters JJ, Brenner DA, Rippe RA, and Behrns KE. Primary cirrhotic hepatocytes resist TGFbeta-induced apoptosis through a ROS-dependent mechanism. J Hepatol 40: 942-951, 2004. (Pubitemid 38670128)
8. Blagosklonny MV, An WG, Romanova LY, Trepel J, Fojo T, and Neckers L. p53 inhibits hypoxia-inducible factorstimulated transcription. J Biol Chem 273: 11995-11998, 1998. (Pubitemid 28240554)
9. Blagosklonny MV, Giannakakou P, Romanova LY, Ryan KM, Vousden KH, and Fojo T. Inhibition of HIF-1-and wild-type p53-stimulated transcription by codon Arg175 p53 mutants with selective loss of functions. Carcinogenesis 22: 861-867, 2001. (Pubitemid 32514949)
10. Bragado P, Armesilla A, Silva A, and Porras A. Apoptosis by cisplatin requires p53 mediated p38alpha MAPK activation through ROS generation. Apoptosis 12: 1733-1742, 2007. (Pubitemid 47106882)
11. Brand K. Aerobic glycolysis by proliferating cells: protection against oxidative stress at the expense of energy yield. J Bioenerg Biomembr 29: 355-364, 1997. (Pubitemid 27498415)
12. Brown DI and Griendling KK. Nox proteins in signal transduction. Free Radic Biol Med 47: 1239-1253, 2009.
13. Budanov AV and Karin M. p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell 134: 451-460, 2008.
14. Budanov AV, Sablina AA, Feinstein E, Koonin EV, and Chumakov PM. Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science 304: 596-600, 2004. (Pubitemid 38541920)
15. Bulavin DV, Saito S, Hollander MC, Sakaguchi K, Anderson CW, Appella E, and Fornace AJ, Jr. Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J 18: 6845-6854, 1999.
16. Burdon RH. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med 18: 775-794, 1995.
17. Buschmann T, Potapova O, Bar-Shira A, Ivanov VN, Fuchs SY, Henderson S, Fried VA,Minamoto T, Alarcon-Vargas D, PincusMR, Gaarde WA, HolbrookNJ, Shiloh Y, and Ronai Z. Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress. Mol Cell Biol 21: 2743-2754, 2001. (Pubitemid 32244919)
18. Buschmann T, Yin Z, Bhoumik A, and Ronai Z. Aminoterminal-derived JNK fragment alters expression and activity of c-Jun, ATF2, and p53 and increases H2O2-induced cell death. J Biol Chem 275: 16590-16596, 2000. (Pubitemid 30398884)
19. Cadigan KM and Liu YI. Wnt signaling: complexity at the surface. J Cell Sci 119: 395-402, 2006.
20. Callapina M, Zhou J, Schmid T, Kohl R, and Brune B. NO restores HIF-1alpha hydroxylation during hypoxia: role of reactive oxygen species. Free Radic BiolMed 39: 925-936, 2005.
21. Cano CE, Gommeaux J, Pietri S, Culcasi M, Garcia S, Seux M, Barelier S, Vasseur S, Spoto RP, Pebusque MJ, Dusetti NJ, Iovanna JL, and Carrier A. Tumor protein 53-induced nuclear protein 1 is a major mediator of p53 antioxidant function. Cancer Res 69: 219-226, 2009.
22. Cantley LC. The phosphoinositide 3-kinase pathway. Science 296: 1655-1657, 2002. (Pubitemid 34579158)
23. Carmona-Cuenca I, Roncero C, Sancho P, Caja L, Fausto N, Fernandez M, and Fabregat I. Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity. J Hepatol 49: 965-976, 2008.
24. Connor KM, Subbaram S, Regan KJ, Nelson KK, Mazurkiewicz JE, Bartholomew PJ, Aplin AE, Tai YT, Aguirre-Ghiso J, Flores SC, and Melendez JA. Mitochondrial H2O2 regulates the angiogenic phenotype via PTEN oxidation. J Biol Chem 280: 16916-16924, 2005. (Pubitemid 41389151)
25. Cooke MS, Evans MD, Dizdaroglu M, and Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 17: 1195-1214, 2003. (Pubitemid 36775767)
26. Cordenonsi M, Dupont S, Maretto S, Insinga A, Imbriano C, and Piccolo S. Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads. Cell 113: 301-314, 2003. (Pubitemid 36556113)
27. Cox AG, Winterbourn CC, and Hampton MB. Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling. Biochem J 425: 313-325, 2009.
28. Chang L and Karin M. Mammalian MAP kinase signalling cascades. Nature 410: 37-40, 2001. (Pubitemid 32225829)
29. Chen D, Li M, Luo J, and Gu W. Direct interactions between HIF-1 alpha and Mdm2 modulate p53 function. J Biol Chem 278: 13595-13598, 2003. (Pubitemid 36799889)
30. Cheng WH, Zheng X, Quimby FR, Roneker CA, and Lei XG. Low levels of glutathione peroxidase 1 activity in selenium-deficient mouse liver affect c-Jun N-terminal kinase activation and p53 phosphorylation on Ser-15 in prooxidant-induced aponecrosis. Biochem J 370: 927-934, 2003. (Pubitemid 36399085)
31. Christophorou MA, Martin-Zanca D, Soucek L, Lawlor ER, Brown-Swigart L, Verschuren EW, and Evan GI. Temporal dissection of p53 function in vitro and in vivo. Nat Genet 37: 718-726, 2005. (Pubitemid 41754888)
32. Derijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M, and Davis RJ. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76: 1025-1037, 1994. (Pubitemid 24106383)
33. Desaint S, Luriau S, Aude JC, Rousselet G, and Toledano MB. Mammalian antioxidant defenses are not inducible by H2O2. J Biol Chem 279: 31157-31163, 2004. (Pubitemid 39037778)
34. Dhar SK, Xu Y, Chen Y, and St. Clair DK. Specificity protein 1-dependent p53-mediated suppression of human manganese superoxide dismutase gene expression. J Biol Chem 281: 21698-21709, 2006. (Pubitemid 44181873)
35. Dolado I, Swat A, Ajenjo N, De Vita G, Cuadrado A, and Nebreda AR. p38alpha MAP kinase as a sensor of reactive oxygen species in tumorigenesis. Cancer Cell 11: 191-205, 2007. (Pubitemid 46209847)
36. Downward J. PI 3-kinase, Akt and cell survival. Semin Cell Dev Biol 15: 177-182, 2004. (Pubitemid 38251646)
37. Drane P, Bravard A, Bouvard V, and May E. Reciprocal down-regulation of p53 and SOD2 gene expressionimplication in p53 mediated apoptosis. Oncogene 20: 430-439, 2001. (Pubitemid 32158223)
38. Drewelus I, Gopfert C, Hippel C, Dickmanns A, Damianitsch K, Pieler T, and Dobbelstein M. p63 antagonizes Wnt-induced transcription. Cell Cycle 9: 580-587, 2010.
39. Feng Z, Hu W, de Stanchina E, Teresky AK, Jin S, Lowe S, and Levine AJ. The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res 67: 3043-3053, 2007. (Pubitemid 46724841)
40. Fiscella M, Zhang H, Fan S, Sakaguchi K, Shen S, Mercer WE, Vande Woude GF, O'Connor PM, and Appella E. Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc Natl Acad Sci USA 94: 6048-6053, 1997. (Pubitemid 27270633)
41. Franklin CC, Rosenfeld-Franklin ME, White C, Kavanagh TJ, and Fausto N. TGFbeta1-induced suppression of glutathione antioxidant defenses in hepatocytes: caspasedependent post-translational and caspase-independent transcriptional regulatory mechanisms. FASEB J 17: 1535-1537, 2003.
42. Fu W, Ma Q, Chen L, Li P, Zhang M, Ramamoorthy S, Nawaz Z, Shimojima T, Wang H, Yang Y, Shen Z, Zhang Y, Zhang X, Nicosia SV, Zhang Y, Pledger JW, Chen J, and Bai W. MDM2 acts downstream of p53 as an E3 ligase to promote FOXO ubiquitination and degradation. J Biol Chem 284: 13987-14000, 2009.
43. Fuchs SY, Adler V, Buschmann T, Yin Z, Wu X, Jones SN, and Ronai Z. JNK targets p53 ubiquitination and degradation in nonstressed cells. Genes Dev 12: 2658-2663, 1998. (Pubitemid 28420646)
44. Fuchs SY, Adler V, Pincus MR, and Ronai Z. MEKK1=JNK signaling stabilizes and activates p53. Proc Natl Acad Sci USA 95: 10541-10546, 1998. (Pubitemid 28413103)
45. Giorgio M, Migliaccio E, Orsini F, Paolucci D, Moroni M, Contursi C, Pelliccia G, Luzi L, Minucci S, Marcaccio M, Pinton P, Rizzuto R, Bernardi P, Paolucci F, and Pelicci PG. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 122: 221-233, 2005. (Pubitemid 41032986)
46. Golden TR, Hinerfeld DA, and Melov S. Oxidative stress and aging: beyond correlation. Aging Cell 1: 117-123, 2002.
47. Gommeaux J, Cano C, Garcia S, Gironella M, Pietri S, Culcasi M, Pebusque MJ, Malissen B, Dusetti N, Iovanna J, and Carrier A. Colitis and colitis-associated cancer are exacerbated in mice deficient for tumor protein 53-induced nuclear protein 1. Mol Cell Biol 27: 2215-2228, 2007. (Pubitemid 46418477)
48. Gottlieb TM, Leal JF, Seger R, Taya Y, and Oren M. Crosstalk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis. Oncogene 21: 1299-1303, 2002. (Pubitemid 34185247)
49. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, and Giaccia AJ. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379: 88-91, 1996. (Pubitemid 26008141)
50. Graeber TG, Peterson JF, Tsai M, Monica K, Fornace AJ, Jr., and Giaccia AJ. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by lowoxygen conditions is independent of p53 status. Mol Cell Biol 14: 6264-6277, 1994.
51. Guertin DA and Sabatini DM. Defining the role of mTOR in cancer. Cancer Cell 12: 9-22, 2007. (Pubitemid 47001784)
52. Hammond EM and Giaccia AJ. The role of p53 in hypoxiainduced apoptosis. Biochem Biophys Res Commun 331: 718-725, 2005.
53. Harwood AJ. Signal transduction in development: holding the key. Dev Cell 2: 384-385, 2002. (Pubitemid 34436567)
54. Haupt Y, Maya R, Kazaz A, and Oren M. Mdm2 promotes the rapid degradation of p53. Nature 387: 296-299, 1997. (Pubitemid 27220766)
55. Hensley K and Floyd RA. Reactive oxygen species and protein oxidation in aging: a look back, a look ahead. Arch Biochem Biophys 397: 377-383, 2002. (Pubitemid 34852306)
56. Hermeking H and Eick D. Mediation of c-Myc-induced apoptosis by p53. Science 265: 2091-2093, 1994.
57. Herrera B, Alvarez AM, Sanchez A, Fernandez M, Roncero C, Benito M, and Fabregat I. Reactive oxygen species (ROS) mediates the mitochondrial-dependent apoptosis induced by transforming growth factor (beta) in fetal hepatocytes. FASEB J 15: 741-751, 2001. (Pubitemid 32245992)
58. Herrera B, Fernandez M, Alvarez AM, Roncero C, Benito M, Gil J, and Fabregat I. Activation of caspases occurs downstream from radical oxygen species production, BclxL down-regulation, and early cytochrome C release in apoptosis induced by transforming growth factor beta in rat fetal hepatocytes. Hepatology 34: 548-556, 2001. (Pubitemid 32786646)
59. Herrera B, Murillo MM, Alvarez-Barrientos A, Beltran J, Fernandez M, and Fabregat I. Source of early reactive oxygen species in the apoptosis induced by transforming growth factor-beta in fetal rat hepatocytes. Free Radic Biol Med 36: 16-26, 2004. (Pubitemid 38068288)
60. Hibi M, Lin A, Smeal T, Minden A, and Karin M. Identification of an oncoprotein-and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 7: 2135-2148, 1993. (Pubitemid 23336140)
61. Hoogeboom D and Burgering BM. Should I stay or should I go: beta-catenin decides under stress. Biochim Biophys Acta 1796: 63-74, 2009.
62. Hoogeboom D, Essers MA, Polderman PE, Voets E, Smits LM, and Burgering BM. Interaction of FOXO with betacatenin inhibits beta-catenin=T cell factor activity. J Biol Chem 283: 9224-9230, 2008.
63. Huang B, Deo D, Xia M, and Vassilev LT. Pharmacologic p53 activation blocks cell cycle progression but fails to induce senescence in epithelial cancer cells. Mol Cancer Res 7: 1497-1509, 2009.
64. Huang C, Ma WY, Maxiner A, Sun Y, and Dong Z. p38 kinase mediates UV-induced phosphorylation of p53 protein at serine 389. J Biol Chem 274: 12229-12235, 1999.
65. Hyun MS, Hur JM, Mun YJ, Kim D, and Woo WH. BBR induces apoptosis in HepG2 cell through an Akt-ASK1-ROSp38MAPKs-linked cascade. J Cell Biochem 109: 329-338, 2010.
66. Ide T, Brown-Endres L, Chu K, Ongusaha PP, Ohtsuka T, El-Deiry WS, Aaronson SA, and Lee SW. GAMT, a p53-inducible modulator of apoptosis, is critical for the adaptive response to nutrient stress. Mol Cell 36: 379-392, 2009.
67. Inoue T, Kato K, Kato H, Asanoma K, Kuboyama A, Ueoka Y, Yamaguchi S, Ohgami T, and Wake N. Level of reactive oxygen species induced by p21Waf1=CIP1 is critical for the determination of cell fate. Cancer Sci 100: 1275-1283, 2009.
68. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, Sundaresan M, Finkel T, and Goldschmidt-Clermont PJ. Mitogenic signaling mediated by oxidants in Rastransformed fibroblasts. Science 275: 1649-1652, 1997. (Pubitemid 27120541)
69. Jaksch M, Paret C, Stucka R, Horn N, Muller-Hocker J, Horvath R, Trepesch N, Stecker G, Freisinger P, Thirion C, Muller J, Lunkwitz R, Rodel G, Shoubridge EA, and Lochmuller H. Cytochrome c oxidase deficiency due to mutations in SCO2, encoding a mitochondrial copperbinding protein, is rescued by copper in human myoblasts. Hum Mol Genet 10: 3025-3035, 2001. (Pubitemid 34083489)
70. Kaidi A, Williams AC, and Paraskeva C. Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat Cell Biol 9: 210-217, 2007. (Pubitemid 46420864)
71. Kamata H, Honda S, Maeda S, Chang L, Hirata H, and Karin M. Reactive oxygen species promote TNFalphainduced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120: 649-661, 2005. (Pubitemid 40343077)
72. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, and Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304-6311, 1991.
73. Kim JY, Ahn HJ, Ryu JH, Suk K, and Park JH. BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1alpha. J Exp Med 199: 113-124, 2004.
74. Kim SJ, Hwang SG, Shin DY, Kang SS, and Chun JS. p38 kinase regulates nitric oxide-induced apoptosis of articular chondrocytes by accumulating p53 viaNFkappa B-dependent transcription and stabilization by serine 15 phosphorylation. J Biol Chem 277: 33501-33508, 2002. (Pubitemid 34984874)
75. Kim SJ, Ju JW, Oh CD, Yoon YM, Song WK, Kim JH, Yoo YJ, Bang OS, Kang SS, and Chun JS. ERK-1=2 and p38 kinase oppositely regulate nitric oxide-induced apoptosis of chondrocytes in association with p53, caspase-3, and differentiation status. J Biol Chem 277: 1332-1339, 2002. (Pubitemid 34968887)
76. Kimelman D and Xu W. beta-catenin destruction complex: insights and questions from a structural perspective. Oncogene 25: 7482-7491, 2006. (Pubitemid 44885747)
77. Kishi H, Nakagawa K, Matsumoto M, Suga M, Ando M, Taya Y, and Yamaizumi M. Osmotic shock induces G1 arrest through p53 phosphorylation at Ser33 by activated p38MAPK without phosphorylation at Ser15 and Ser20. J Biol Chem 276: 39115-39122, 2001.
78. Knebel A, Rahmsdorf HJ, Ullrich A, and Herrlich P. Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents. EMBO J 15: 5314-5325, 1996. (Pubitemid 26336214)
79. Koch OR, Fusco S, Ranieri SC, Maulucci G, Palozza P, Larocca LM, Cravero AA, Farre SM, De Spirito M, Galeotti T, and Pani G. Role of the life span determinant P66(shcA) in ethanol-induced liver damage. Lab Invest 88: 750-760, 2008. (Pubitemid 351896640)
80. Kondoh H, Lleonart ME, Gil J, Wang J, Degan P, Peters G, Martinez D, Carnero A, and Beach D. Glycolytic enzymes can modulate cellular life span. Cancer Res 65: 177-185, 2005. (Pubitemid 40070808)
81. Kops GJ, Dansen TB, Polderman PE, Saarloos I, Wirtz KW, Coffer PJ, Huang TT, Bos JL, Medema RH, and Burgering BM. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419: 316-321, 2002.
82. Kurz EU, Douglas P, and Lees-Miller SP. Doxorubicin activates ATM-dependent phosphorylation of multiple downstream targets in part through the generation of reactive oxygen species. J Biol Chem 279: 53272-53281, 2004. (Pubitemid 40051831)
83. Kwon J, Lee SR, Yang KS, Ahn Y, Kim YJ, Stadtman ER, and Rhee SG. Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors. Proc Natl Acad Sci USA 101: 16419-16424, 2004. (Pubitemid 39557728)
84. Lee AC, Fenster BE, Ito H, Takeda K, Bae NS, Hirai T, Yu ZX, Ferrans VJ, Howard BH, and Finkel T. Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J Biol Chem 274: 7936-7940, 1999.
85. Leto TL, Morand S, Hurt D, and Ueyama T. Targeting and regulation of reactive oxygen species generation by Nox family NADPH oxidases. Antioxid Redox Signal 11: 2607-2619, 2009.
86. Levanon D, Goldstein RE, Bernstein Y, Tang H, Goldenberg D, Stifani S, Paroush Z, and Groner Y. Transcriptional repression by AML1 and LEF-1 is mediated by the TLE=Groucho corepressors. Proc Natl Acad Sci USA 95: 11590-11595, 1998. (Pubitemid 28460459)
87. Levine AJ. The common mechanisms of transformation by the small DNA tumor viruses: the inactivation of tumor suppressor gene products: p53. Virology 384: 285-293, 2009.
88. Levine AJ, Hu W, and Feng Z. The P53 pathway: what questions remain to be explored? Cell Death Differ 13: 1027-1036, 2006.
89. Li H and Zhan M. Systematic intervention of transcription for identifying network response to disease and cellular phenotypes. Bioinformatics 22: 96-102, 2006. (Pubitemid 43057013)
90. Li M, Zhou JY, Ge Y, Matherly LH, and Wu GS. The phosphatase MKP1 is a transcriptional target of p53 involved in cell cycle regulation. J Biol Chem 278: 41059-41068, 2003. (Pubitemid 37280929)
91. Liu B, Chen Y, and St. Clair DK. ROS and p53: a versatile partnership. Free Radic Biol Med 44: 1529-1535, 2008.
92. Liu G and Chen X. The ferredoxin reductase gene is regulated by the p53 family and sensitizes cells to oxidative stress-induced apoptosis. Oncogene 21: 7195-7204, 2002. (Pubitemid 35305606)
93. Liu J, Stevens J, Rote CA, Yost HJ, Hu Y, Neufeld KL, White RL, and Matsunami N. Siah-1 mediates a novel betacatenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol Cell 7: 927-936, 2001. (Pubitemid 32525740)
94. Lowe SW, Schmitt EM, Smith SW, Osborne BA, and Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849, 1993. (Pubitemid 23132161)
95. Macip S, Igarashi M, Berggren P, Yu J, Lee SW, and Aaronson SA. Influence of induced reactive oxygen species in p53-mediated cell fate decisions. Mol Cell Biol 23: 8576-8585, 2003. (Pubitemid 37433363)
96. Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, Hurley PJ, Bunz F, and Hwang PM. p53 regulates mitochondrial respiration. Science 312: 1650-1653, 2006. (Pubitemid 43902663)
97. Matsuzawa SI and Reed JC. Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol Cell 7: 915-926, 2001. (Pubitemid 32525739)
98. Meek DW. Tumour suppression by p53: a role for the DNA damage response? Nat Rev Cancer 9: 714-723, 2009.
99. Mehdi MZ, Azar ZM, and Srivastava AK. Role of receptor and nonreceptor protein tyrosine kinases in H2O2-induced PKB and ERK1=2 signaling. Cell Biochem Biophys 47: 1-10, 2007. (Pubitemid 46570693)
100. Mellert H, Sykes SM, Murphy ME, and McMahon SB. The ARF=oncogene pathway activates p53 acetylation within the DNA binding domain. Cell Cycle 6: 1304-1306, 2007. (Pubitemid 47327961)
101. Milne DM, Campbell LE, Campbell DG, and Meek DW. p53 is phosphorylated in vitro and in vivo by an ultraviolet radiation-induced protein kinase characteristic of the c-Jun kinase, JNK1. J Biol Chem 270: 5511-5518, 1995.
102. Miyashita T and Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299, 1995.
103. Moiseeva O, Mallette FA, Mukhopadhyay UK, Moores A, and Ferbeyre G. DNA damage signaling and p53-dependent senescence after prolonged beta-interferon stimulation. Mol Biol Cell 17: 1583-1592, 2006. (Pubitemid 44011578)
104. Monte M and Sacerdote de Lustig E. [Free radicals of oxygen and superoxide dismutase. Biological and medical aspects]. Medicina (B Aires) 54: 61-68, 1994. (Pubitemid 24117269)
105. Monte M, Simonatto M, Peche LY, Bublik DR, Gobessi S, Pierotti MA, Rodolfo M, and Schneider C. MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents. Proc Natl Acad Sci USA 103: 11160-11165, 2006. (Pubitemid 44156489)
106. Moon RT, Bowerman B, Boutros M, and Perrimon N. The promise and perils of Wnt signaling through beta-catenin. Science 296: 1644-1646, 2002. (Pubitemid 34579151)
107. Nakano K and Vousden KH. PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7: 683-694, 2001. (Pubitemid 32706359)
108. Nemoto S and Finkel T. Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 295: 2450-2452, 2002. (Pubitemid 34270258)
109. Nogueira V, Park Y, Chen CC, Xu PZ, Chen ML, Tonic I, Unterman T, and Hay N. Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 14: 458-470, 2008.
110. Novo E and Parola M. Redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogenesis Tissue Repair 1: 1-5, 2008.
111. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T, and Tanaka N. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288: 1053-1058, 2000. (Pubitemid 30324238)
112. Okamura S, Arakawa H, Tanaka T, Nakanishi H, Ng CC, Taya Y, Monden M, and Nakamura Y. p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis. Mol Cell 8: 85-94, 2001. (Pubitemid 32772907)
113. Park HJ, Carr JR, Wang Z, Nogueira V, Hay N, Tyner AL, Lau LF, Costa RH, and Raychaudhuri P. FoxM1, a critical regulator of oxidative stress during oncogenesis. EMBO J 28: 2908-2918, 2009.
114. Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M, Saito S, Higashimoto Y, Appella E, Minucci S, Pandolfi PP, and Pelicci PG. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 406: 207-210, 2000. (Pubitemid 30469006)
115. Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P, and Olivier M. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat 28: 622-629, 2007. (Pubitemid 46744292)
116. Pilarsky C, Wenzig M, Specht T, Saeger HD, and Grutzmann R. Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data. Neoplasia 6: 744-750, 2004. (Pubitemid 40041492)
117. Plas DR and Thompson CB. Akt-dependent transformation: there is more to growth than just surviving. Oncogene 24: 7435-7442, 2005. (Pubitemid 41637983)
118. Polyak K, Xia Y, Zweier JL, Kinzler KW, and Vogelstein B. A model for p53-induced apoptosis. Nature 389: 300-305, 1997. (Pubitemid 27406646)
119. Ravi R, Mookerjee B, Bhujwalla ZM, Sutter CH, Artemov D, Zeng Q, Dillehay LE, Madan A, Semenza GL, and Bedi A. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev 14: 34-44, 2000. (Pubitemid 30051577)
120. Rivera A and Maxwell SA. The p53-induced gene-6 (proline oxidase) mediates apoptosis through a calcineurindependent pathway. J Biol Chem 280: 29346-29354, 2005. (Pubitemid 41161390)
121. Ruan K, Song G, and Ouyang G. Role of hypoxia in the hallmarks of human cancer. J Cell Biochem 107: 1053-1062, 2009.
122. Ruiz-Lozano P, Hixon ML,WagnerMW, Flores AI, Ikawa S, Baldwin AS, Jr., Chien KR, and Gualberto A. p53 is a transcriptional activator of the muscle-specific phosphoglycerate mutase gene and contributes in vivo to the control of its cardiac expression. Cell Growth Differ 10: 295-306, 1999. (Pubitemid 29242596)
123. Sablina AA, Budanov AV, Ilyinskaya GV, Agapova LS, Kravchenko JE, and Chumakov PM. The antioxidant function of the p53 tumor suppressor. Nat Med 11: 1306-1313, 2005. (Pubitemid 41752911)
124. Sager R. Senescence as a mode of tumor suppression. Environ Health Perspect 93: 59-62, 1991.
125. Sanchez-Prieto R, Rojas JM, Taya Y, and Gutkind JS. A role for the p38 mitogen-acitvated protein kinase pathway in the transcriptional activation of p53 on genotoxic stress by chemotherapeutic agents. Cancer Res 60: 2464-2472, 2000. (Pubitemid 30262438)
126. Sanchez-Prieto R, Sanchez-Arevalo VJ, Servitja JM, and Gutkind JS. Regulation of p73 by c-Abl through the p38 MAP kinase pathway. Oncogene 21: 974-979, 2002. (Pubitemid 34146311)
127. Santoni-Rugiu E, Jensen MR, Factor VM, and Thorgeirsson SS. Acceleration of c-myc-induced hepatocarcinogenesis by co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption. Am J Pathol 154: 1693-1700, 1999. (Pubitemid 29262851)
128. Sarbassov DD and Sabatini DM. Redox regulation of the nutrient-sensitive raptor-mTOR pathway and complex. J Biol Chem 280: 39505-39509, 2005. (Pubitemid 41713908)
129. Schmid T, Zhou J, Kohl R, and Brune B. p300 relieves p53-evoked transcriptional repression of hypoxia-inducible factor-1 (HIF-1). Biochem J 380: 289-295, 2004. (Pubitemid 38725754)
130. Schweikl H, Hiller KA, Eckhardt A, Bolay C, Spagnuolo G, Stempfl T, and Schmalz G. Differential gene expression involved in oxidative stress response caused by triethylene glycol dimethacrylate. Biomaterials 29: 1377-1387, 2008.
131. Seifert A, Taubert H, Hombach-Klonisch S, Fischer B, and Navarrete Santos A. TCDD mediates inhibition of p53 and activation of ERalpha signaling in MCF-7 cells at moderate hypoxic conditions. Int J Oncol 35: 417-424, 2009.
132. Serrano M, Lin AW, McCurrach ME, Beach D, and Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88: 593-602, 1997. (Pubitemid 27152402)
133. Shi Y and Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113: 685-700, 2003. (Pubitemid 36724933)
134. Shimada K, Nakamura M, Ishida E, Kishi M, and Konishi N. Roles of p38-and c-jun NH2-terminal kinase-mediated pathways in 2-methoxyestradiol-induced p53 induction and apoptosis. Carcinogenesis 24: 1067-1075, 2003. (Pubitemid 36827258)
135. Siegel PM and Massague J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer 3: 807-821, 2003.
136. Simon HU, Haj-Yehia A, and Levi-Schaffer F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5: 415-418, 2000. (Pubitemid 32162623)
137. Stambolic V, MacPherson D, Sas D, Lin Y, Snow B, Jang Y, Benchimol S, and Mak TW. Regulation of PTEN transcription by p53. Mol Cell 8: 317-325, 2001. (Pubitemid 32831549)
138. Stambolsky P, Weisz L, Shats I, Klein Y, Goldfinger N, Oren M, and Rotter V. Regulation of AIF expression by p53. Cell Death Differ 13: 2140-2149, 2006. (Pubitemid 44742697)
139. Tan M, Li S, Swaroop M, Guan K, Oberley LW, and Sun Y. Transcriptional activation of the human glutathione peroxidase promoter by p53. J Biol Chem 274: 12061-12066, 1999.
140. Terada LS. Specificity in reactive oxidant signaling: think globally, act locally. J Cell Biol 174: 615-623, 2006.
141. Teramoto T, Kiss A, and Thorgeirsson SS. Induction of p53 and Bax during TGF-beta 1 initiated apoptosis in rat liver epithelial cells. Biochem Biophys Res Commun 251: 56-60, 1998. (Pubitemid 28498062)
142. Tomasini R, Samir AA, Carrier A, Isnardon D, Cecchinelli B, Soddu S, Malissen B, Dagorn JC, Iovanna JL, and Dusetti NJ. TP53INP1s and homeodomain-interacting protein kinase-2 (HIPK2) are partners in regulating p53 activity. J Biol Chem 278: 37722-37729, 2003. (Pubitemid 37175297)
143. Tomasini R, Samir AA, Pebusque MJ, Calvo EL, Totaro S, Dagorn JC, Dusetti NJ, and Iovanna JL. P53-dependent expression of the stress-induced protein (SIP). Eur J Cell Biol 81: 294-301, 2002. (Pubitemid 34568210)
144. Tomkova K, Belkhiri A, El-Rifai W, and Zaika AI. p73 isoforms can induce T-cell factor-dependent transcription in gastrointestinal cells. Cancer Res 64: 6390-6393, 2004. (Pubitemid 39297891)
145. Tormos KV and Chandel NS. Inter-connection between mitochondria and HIFs. J Cell Mol Med 14: 795-804, 2010.
146. Trachootham D, Lu W, Ogasawara MA, Nilsa RD, and Huang P. Redox regulation of cell survival. Antioxid Redox Signal 10: 1343-1374, 2008.
147. Trinei M, Giorgio M, Cicalese A, Barozzi S, Ventura A, Migliaccio E, Milia E, Padura IM, Raker VA, Maccarana M, Petronilli V,Minucci S, Bernardi P, Lanfrancone L, and Pelicci PG. A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis. Oncogene 21: 3872-3878, 2002. (Pubitemid 34620855)
148. Trotman LC, Alimonti A, Scaglioni PP, Koutcher JA, Cordon-Cardo C, and Pandolfi PP. Identification of a tumour suppressor network opposing nuclear Akt function. Nature 441: 523-527, 2006. (Pubitemid 44050155)
149. Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol 552: 335-344, 2003. (Pubitemid 37321833)
150. Ueda K, Arakawa H, and Nakamura Y. Dual-specificity phosphatase 5 (DUSP5) as a direct transcriptional target of tumor suppressor p53. Oncogene 22: 5586-5591, 2003. (Pubitemid 37102694)
151. Ueda Y, Hijikata M, Takagi S, Takada R, Takada S, Chiba T, and Shimotohno K. p73beta, a variant of p73, enhances Wnt=beta-catenin signaling in Saos-2 cells. Biochem Biophys Res Commun 283: 327-333, 2001. (Pubitemid 32924692)
152. Ueno M, Masutani H, Arai RJ, Yamauchi A, Hirota K, Sakai T, Inamoto T, Yamaoka Y, Yodoi J, and Nikaido T. Thioredoxin-dependent redox regulation of p53-mediated p21 activation. J Biol Chem 274: 35809-35815, 1999. (Pubitemid 129512885)
153. Weinberg F and Chandel NS. Reactive oxygen speciesdependent signaling regulates cancer. Cell Mol Life Sci 66: 3663-3673, 2009.
154. Wierstra I and Alves J. FOXM1, a typical proliferationassociated transcription factor. Biol Chem 388: 1257-1274, 2007. (Pubitemid 350135573)
155. Wu GS. The functional interactions between the p53 and MAPK signaling pathways. Cancer Biol Ther 3: 156-161, 2004.
156. Wu J, Jin YJ, Calaf GM, Huang WL, and Yin Y. PAC1 is a direct transcription target of E2F-1 in apoptotic signaling. Oncogene 26: 6526-6535, 2007. (Pubitemid 47530605)
157. Wullschleger S, Loewith R, and Hall MN. TOR signaling in growth and metabolism. Cell 124: 471-484, 2006. (Pubitemid 43199434)
158. Wyss M and Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev 80: 1107-1213, 2000. (Pubitemid 30452013)
159. Yamamura Y, Lee WL, Goh MX, and Ito Y. Role of TAp73alpha in induction of apoptosis by transforming growth factor-beta in gastric cancer cells. FEBS Lett 582: 2663-2667, 2008.
160. Yang B, O'Herrin SM, Wu J, Reagan-Shaw S, Ma Y, Bhat KM, Gravekamp C, Setaluri V, Peters N, Hoffmann FM, Peng H, Ivanov AV, Simpson AJ, and Longley BJ. MAGEA, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGEpositive cell lines. Cancer Res 67: 9954-9962, 2007. (Pubitemid 47621245)
161. Yang J, Ahmed A, Poon E, Perusinghe N, de Haven Brandon A, Box G, Valenti M, Eccles S, Rouschop K, Wouters B, and Ashcroft M.Small-molecule activation of p53 blocks hypoxiainducible factor 1alpha and vascular endothelial growth factor expression in vivo and leads to tumor cell apoptosis in normoxia and hypoxia. Mol Cell Biol 29: 2243-2253, 2009.
162. Yin Y, Liu YX, Jin YJ, Hall EJ, and Barrett JC. PAC1 phosphatase is a transcription target of p53 in signalling apoptosis and growth suppression. Nature 422: 527-531, 2003. (Pubitemid 36433648)
163. Yoon KA, Nakamura Y, and Arakawa H. Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses. J Hum Genet 49: 134-140, 2004. (Pubitemid 38506727)
164. Yoshida K, Liu H, and Miki Y. Protein kinase C delta regulates Ser46 phosphorylation of p53 tumor suppressor in the apoptotic response to DNA damage. J Biol Chem 281: 5734-5740, 2006. (Pubitemid 43847672)
165. Young CD and Anderson SM. Sugar and fat-that's where it's at: metabolic changes in tumors. Breast Cancer Res 10: 202, 2008.
166. Zhao Y, Chaiswinga L, Velez JM, Batinic-Haberle I, Colburn NH, Oberley TD, and St. Clair DK. p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase. Cancer Res 65: 3745-3750, 2005. (Pubitemid 40616352)
167. Zhu Y, Mao XO, Sun Y, Xia Z, and Greenberg DA. p38 Mitogen-activated protein kinase mediates hypoxic regulation of Mdm2 and p53 in neurons. J Biol Chem 277: 22909-22914, 2002. (Pubitemid 34967274)